ACCENTMIC
LAX.SH
ACCENT MICROCELL LIMITED·PHARMACEUTICALS 66.37·Pharmaceuticals & Biotechnology Companies
Price
616.65
-2.93%O:642.35
H:642.35
L:615.75
C:616.65
52W Range
253731.7
+144%/-16%
Market Cap
₹1,479.28 Cr
Traded: ₹1.56 Cr (0.11%) 0.0x
Free Float: ₹472.63 Cr (0.33% of FF traded)
Volume · 60D trend
25 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
1W:+0% 1M:-8% 3M:+3% 6M:+36% 12M:+89%
RS Score
SEEM
NOUS
BNF
SMA Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
P/E26.0
P/B4.9
P/S3.8
EV/EBIT259523318.7
Business Strength
ROE18.6%
ROCE24.9%
OPM16.3%
NPM12.6%
Growth (3Y CAGR)
EPS+32.7%
Sales+21.0%
Profit+53.0%
3Y Return--
Balance Sheet
Debt/Equity0.0
Debt0.62 Cr
Pledge0.0%
CWIP/Fixed Asset241.1%
Cash Position
CFO/NP43.2%
FCF-68.5 Cr
FCF 3Y Avg-82.6 Cr
Cash/MCap2.0%
Others
Div Yield0.1%
Div Payout5.0%
Cash Conv. Cycle117 days
Tradeable Free Float32.0%
ACCENTMIC616.65 -2.93% NSESME20% 14 Oct
NOUS
BNF
MCap₹1,479.28 Cr1.5K Cr
Vol25 K
RVol
Del%
TVal1.56 Cr
RS
SEEM
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +21.0% | +21.0% | -- | +38.0% | Stable |
| ROE | -- | +21.0% | +21.0% | -- | -- | Stable |
| Return | -- | -- | -- | +171.0% | -- | -- |
| Profit | -- | +54.0% | +53.0% | -- | +64.0% | Stable |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Debt / Equity0.00
Interest Coverage1.6x
Promoter Pledge0.0%
Borrowings1 Cr
Efficiency
Receivable Days95 days
Inventory Days55 days
Payable Days33 days
Cash Conversion cycle117 days
Cash Position
Operating Cash Flow19 Cr
Investing Cash Flow-49 Cr
Financing Cash Flow36 Cr
Free Cash Flow-69 Cr
Detailed Financials
Sep 2026PDF ↗ | Mar 2026PDF ↗ | Sep 2025PDF ↗ | Mar 2025PDF ↗ | Sep 2024PDF ↗ | Mar 2024PDF ↗ | Sep 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|
| Sales | 175 | 210 | 139 | 139 | 126 | 139 | 107 |
| Expenses | 134 | 177 | 115 | 115 | 107 | 119 | 87 |
| Operating Profit | 41 | 33 | 24 | 23 | 19 | 20 | 20 |
| Other Income | 3 | 4 | 3 | 3 | 3 | 2 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 2 | 3 | 2 | 2 | 2 | 2 | 2 |
| Profit Before Tax | 41 | 34 | 24 | 24 | 20 | 19 | 17 |
| Tax % | 25.0% | 25.0% | 25.0% | 32.0% | 16.0% | 17.0% | 18.0% |
| Net Profit | 31 | 26 | 18 | 17 | 16 | 16 | 14 |
| Exceptional Items | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| EPS (Rs) | 13.0 | 10.8 | 7.5 | 6.9 | 6.9 | 6.7 | 8.0 |
| Sales Growth (YoY) | 25.9% | 51.1% | 10.3% | 0.0% | 17.8% | -- | -- |
| Sales Growth (QoQ) | -16.7% | 51.1% | 0.0% | 10.3% | -9.3% | 29.9% | -- |
| OP Growth (YoY) | 70.8% | 43.5% | 26.3% | 15.0% | -5.0% | -- | -- |
| OP Growth (QoQ) | -- | -- | -- | -- | -- | -- | -- |
| Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | 72.2% | 55.4% | 9.8% | 3.3% | -14.4% | -- | -- |
| EPS Growth (QoQ) | 20.6% | 42.8% | 8.8% | 0.9% | 2.4% | -16.4% | -- |
| OP Margin | 23.4% | 15.7% | 17.3% | 16.6% | 15.1% | 14.4% | 18.7% |
| Net Margin | 17.7% | 12.4% | 12.9% | 12.2% | 12.7% | 11.5% | 13.1% |
| Material Cost % | 52.0% | 63.0% | 60.0% | 60.0% | 62.0% | 63.0% | 54.0% |
| Employee Cost % | 7.0% | 5.0% | 6.0% | 6.0% | 5.0% | 5.0% | 5.0% |
| P/S | 3.84 | 4.66 | -- | -- | -- | -- | -- |
| P/E | 26.00 | 37.11 | -- | -- | -- | -- | -- |
| P/B | 4.87 | 5.90 | -- | -- | -- | -- | -- |